title: [Retinoprotective therapy of diabetes macular edema in elderly patients].
abstract: Treatment of elderly patients with diabetes macular edema is a complex and multistage task. To remove these pathologic conditions on retina in macular edema the photocoagulation is used. However the elevation of treatment efficiency of patients with pathology in the central zone remains the actual problem as the results of laser therapy are not always satisfactory and reduction of visual acuity aggravates the life quality of elderly patients. Citomedin retinalamin is used to increase the photocoagulation efficiency of macular edema in diabetes retinopathy. This helps to solve the problems defined.
authors.forename: S V
authors.initials: SV
authors.lastname: Kharintseva
mesh_terms: D000368:Aged; D003930:Diabetic Retinopathy / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006401:Hematologic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D017075:Laser Coagulation / Q000009:adverse effects* / Q000379:methods; D008269:Macular Edema / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D008297:Male; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects; D020011:Protective Agents / Q000008:administration & dosage / Q000009:adverse effects; D012160:Retina / Q000187:drug effects* / Q000503:physiopathology; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects*
chemical_list: D006401:Hematologic Agents; D010455:Peptides; D020011:Protective Agents; C503555:retinalamin